On July 29, ALI HEALTH rose 3.21% in regular trading, trading at HKD 3.53 per share, with turnover of approximately HKD 58.03 million.
On the news front, ALI HEALTH's medical AI platform \"Hydrogen Ion\" has successively reached content cooperation agreements with NEJM (The New England Journal of Medicine), JAMA (Journal of the American Medical Association), and BMJ (British Medical Journal), becoming the first AI platform in China to secure full-text content authorization from all three top global medical journals. The NEJM deal grants exclusive access to all publications and multimedia resources dating back to 1990 for individual physician users in China. This milestone significantly deepens the company's content moat in the AI healthcare space.
Additionally, ALI HEALTH recently signed a strategic cooperation agreement with Tasly Pharmaceutical and PegBio regarding GLP-1RA drugs, aiming to jointly advance innovative drug development and commercialization. Within the Internet and Direct Marketing Retail sector, peer stock JD HEALTH rose 4.74% on the same day, reflecting broadly positive sentiment across the digital health segment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments